Pentagon Mandates Annual Testosterone Screening for Service Members Aged 30 and Older

The Pentagon has announced a new requirement for all active-duty and reserve service members aged 30 and older to undergo annual testosterone deficiency screenings. This decision follows advocacy from veterans like Chad Robichaux, who experienced hormonal imbalances after returning from military service. The initiative aims to establish a baseline for testosterone levels across the military and provide targeted therapy when necessary. Secretary of War Pete Hegseth stated that this measure will help address hormonal issues that have previously gone undetected. The policy will apply to both men and women, although details on how testosterone deficiency will be defined for women remain unclear. The Pentagon has not provided specific numbers on how many service members will be affected by this mandate, but demographic data indicates that over 451,000 active-duty members are aged 31 or older. The new directive reflects ongoing discussions in the medical community regarding the treatment of symptoms like fatigue and depression, which may stem from hormonal disorders rather than solely mental health issues. The Endocrine Society has expressed caution about the broad mandate, emphasizing that screening should not automatically lead to treatment and that a diagnosis should be based on symptoms and multiple test results.